<i>In</i> <i>vivo</i>, combined therapy in the transient middle cerebral artery occlusion mouse model reduced cerebral infarction and improved neurological outcomes, accompanied by NLRP3/GSDMD downregulation and hippocampal neuron preservation. This evidence concerns the gene GSDMD and brain infarction.